Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
554.50    1.00 (0.18%)
Bid:
554.50
Ask:
555.00
Spread: 0.50 (0.09%)
Market Cap: £2.45b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

6 Sep 2019 10:15

RNS Number : 4930L
Tate & Lyle PLC
06 September 2019
 

 

Tate & Lyle PLC

 

Notification of transaction by Person Discharging Managerial Responsibilities

 

Tate & Lyle PLC (the 'Company') was informed that 15,064 ordinary shares of 25 pence each in the capital of the Company ('Shares') were released on 4 September 2019 to Andrew Taylor, a Person Discharging Managerial Responsibilities, in accordance with the Restricted Share Award that was granted to him on 24 November 2017. 4,414 shares were withheld to satisfy certain tax obligations arising on the release of the Shares. As a result, Mr. Taylor acquired and retained a total of 10,650 Shares. For tax purposes, the market value of the Shares, being the average of the two closing prices on the date of the transaction, was 743 pence per share. No consideration was paid for the acquisition of these Shares.

 

The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Claire-Marie O'Grady

Company Secretary

6 September 2019

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew Taylor

2.

Reason for the notification

a)

Position / status

PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b)

Nature of the transaction

Acquisition of shares following the exercise of nil-cost conditional awards over shares for no consideration.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

10,650

d)

Aggregated information

- Aggregated volume

- Price

 

 

10,650

 

Nil

e)

Date of the transaction

2019-09-04

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUNUWRKVAKRRR
Date   Source Headline
30th Jun 202612:54 pmRNSForm 8.3 - Tate & Lyle plc
30th Jun 202612:35 pmRNSForm 8.3 - Tate & Lyle plc
30th Jun 202612:34 pmRNSForm 8.3 Tate & Lyle Plc
30th Jun 202611:50 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
30th Jun 202611:45 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
30th Jun 202611:39 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
30th Jun 202611:13 amRNS20260629_TATE & LYLE_8.5 EPT RI_UK_MLI
30th Jun 202610:40 amRNSForm 8.3 - Tate & Lyle plc
30th Jun 202610:34 amRNSForm 8.5 (EPT/RI)-TATE & LYLE PLC
30th Jun 202610:05 amRNSForm 8.3 Tate & Lyle plc
30th Jun 20269:14 amRNSForm 8.5 (EPT/RI)
30th Jun 20267:00 amRNSForm 8.5 (EPT/RI)- Tate & Lyle plc Amend
30th Jun 20267:00 amRNSForm 8.5 (EPT/RI)- Tate & Lyle plc Amend
29th Jun 20263:25 pmRNSForm 8.3 TATE & LYLE PLC
29th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
29th Jun 20262:35 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
29th Jun 20262:08 pmRNSForm 8.3 - Tate & Lyle plc
29th Jun 20261:58 pmRNSForm 8.3 Tate & Lyle Plc
29th Jun 20261:03 pmRNSForm 8.3 Tate & Lyle Plc
29th Jun 202612:40 pmRNSForm 8.3 - Tate & Lyle plc
29th Jun 202611:21 amRNS20260626_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
29th Jun 202611:19 amRNS20260626_TATE & LYLE_8.5 EPT RI_UK_MLI
29th Jun 202611:18 amRNSForm 8.3 - Tate & Lyle Plc
29th Jun 202611:17 amRNSForm 8.5 (EPT/NON-RI) - TATE LYLE PLC
29th Jun 202611:13 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle plc
29th Jun 202611:04 amRNSForm 8.5 (EPT/RI) - Tate & Lyle plc
29th Jun 202610:59 amRNSForm 8.5 (EPT/RI)-TATE & LYLE PLC
29th Jun 20269:15 amRNSForm 8.5 (EPT/RI) - Amendment
29th Jun 20269:10 amRNSForm 8.5 (EPT/RI)
26th Jun 20266:22 pmRNSForm 8.3 TATE & LYLE PLC Replacement
26th Jun 20263:36 pmRNSForm 8.3 - Tate & Lyle plc
26th Jun 20263:12 pmRNSForm 8.3 TATE & LYLE PLC
26th Jun 20263:06 pmRNSForm 8.3 - Tate & Lyle plc
26th Jun 20262:59 pmRNSForm 8.3 - Tate & Lyle plc
26th Jun 20262:57 pmRNSForm 8.3 TATE & LYLE PLC Replacement
26th Jun 20262:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
26th Jun 20261:33 pmRNSForm 8.3 Tate & Lyle Plc
26th Jun 20261:16 pmRNSForm 8.3 Tate & Lyle plc
26th Jun 202612:50 pmRNSForm 8.3 Tate & Lyle Plc
26th Jun 202612:26 pmRNSForm 8.3 - TATE & LYLE PLC
26th Jun 202611:49 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
26th Jun 202611:35 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
26th Jun 202611:23 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
26th Jun 202611:17 amRNS20260625_TATE & LYLE_8.5 EPT RI_UK_MLI
26th Jun 202611:16 amRNS20260625_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
26th Jun 202610:19 amRNSForm 8.3 Tate n Lyle plc
26th Jun 20269:24 amRNSForm 8.5 (EPT/RI)
25th Jun 20263:25 pmRNSForm 8.3 TATE & LYLE PLC
25th Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
25th Jun 20262:52 pmRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.